Sasanlimab_CREST_Protocol_Video_Abstract(2).mp4 (13.49 MB)
CREST: Phase III study of sasanlimab and BCG for patients with BCG-naïve high-risk non-muscle-invasive bladder cancer - supplementary material
media
posted on 2024-01-08, 10:19 authored by Gary D. Steinberg, Neal D Shore, Joan Palou Redorta, Matthew D Galsky, Jens Bedke, Ja Hyeon Ku, Michal Kretkowski, Hailong Hu, Konstantin Penkov, Jennifer J Vermette, Jamal C Tarazi, Alison E Randall, Kristen J. Pierce, Daniel R. Saltzstein, Thomas B PowlesSupplementary video
